Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Surveillance of CMV Terminase Gene Mutations in Allogeneic Hematopoietic Stem Cell Transplant Recipients Receiving Letermovir Prophylaxis.

Journal of medical virology·2026
Same author

ALLOPLUS: allogeneic hematopoietic stem cell transplantation in children and adult people living with human immunodeficiency virus, a retrospective study of the SFGM-TC.

Bone marrow transplantation·2026
Same author

CPX-351 before allogeneic stem cell transplantation, a real-world French experience.

Haematologica·2026
Same author

Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

American journal of hematology·2026
Same author

[Allogeneic haematopoietic stem cell transplantation in myelofibrosis: Patient selection, pre-transplant preparation and harmonisation of practices (SFGM-TC)].

Bulletin du cancer·2026
Same author

Donor cell-derived haematological neoplasms after allogeneic haematopoietic cell transplantation: recommendations from the EBMT Practice Harmonisation and Guidelines Committee.

The Lancet. Haematology·2026

相关实验视频

Updated: May 12, 2026

A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation
08:05

A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation

Published on: June 8, 2018

11.6K

用于治疗胰腺管腺癌的电穿孔,临床前和临床研究的系统综述

Gabriel Marcellier1, Theo Leberre2, Paul Rivallin1

  • 1Beaujon Hospital, Endoscopy Unit, 92100 Clichy, France.

Clinical and translational gastroenterology
|August 29, 2025
PubMed
概括

电穿孔疗法如电化学疗法 (ECT) 和电免疫疗法对胰腺癌治疗具有前景,而不可逆转的电穿孔 (IRE) 则存在安全性和有效性问题.

更多相关视频

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

11.4K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

903

相关实验视频

Last Updated: May 12, 2026

A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation
08:05

A Syngeneic Pancreatic Cancer Mouse Model to Study the Effects of Irreversible Electroporation

Published on: June 8, 2018

11.6K
Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

11.4K
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

903

科学领域:

  • 癌症学
  • 医疗技术
  • 免疫疗法

背景情况:

  • 胰腺管腺癌 (PDAC) 具有侵略性,治疗选择有限.
  • 包括电化学疗法 (ECT) 和不可逆向电穿孔 (IRE) 在内的电穿孔疗法正在被探索为替代方案.
  • 这些方法,包括电免疫疗法,可以提高治疗效率和免疫反应.

研究的目的:

  • 系统地审查ECT,IRE和PDAC电免疫疗法的效率和安全性.
  • 评估基于电穿孔的治疗方法作为潜在的免疫疗法增强剂.

主要方法:

  • 在Medline,Embase,Cochrane和Google-Scholar中进行系统的文献搜索.
  • 在研究选择和数据提取方面遵循PRISMA指南.
  • 电磁疗法和电免疫疗法研究的独立描述;IRE数据的总体分析.

主要成果:

  • 在PDAC (临床前和人体模型) 中,有15项研究表明ECT的安全性和有效性是有希望的.
  • 在38项IRE临床研究 (2245名患者) 中,平均存活时间为17. 2个月,但不良事件发生率为36%.
  • 在PDAC模型中,对电免疫治疗的研究表明了显著的免疫强化.

结论:

  • 在PDAC治疗中的电穿孔:系统审查结果.
  • 由于不良事件,分析建议不要使用IRE.
  • 电磁疗法和电免疫疗法对PDAC治疗有潜在的益处.